Takeda to Sell Consumer Unit to Blackstone for $2.3 Billion

Published August 24, 2020

Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health-care business for 242 billion yen ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years.